Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-09-01 Purchase | 2022-09-01 4:28 pm | Adagio Therapeutics Inc. | ADGI | Hering David Chief Executive Officer | 8,000 | $4.52 | $36,160 | 8,000 (Direct) | View |
| 2022-08-17 Purchase | 2022-08-19 4:57 pm | Adagio Therapeutics Inc. | ADGI | Elia Marc M28 Capital Management LP See Footnote 5 | 2,850,000 | $4.2788 | $12,194,680 | 9,248,250 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-12-14 Option Award | 2022-12-16 5:20 pm | N/A 2032-12-13 | Invivyd Inc. | IVVD | Dabora Rebecca Chief Tech and Manuf Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-12-14 Option Award | 2022-12-16 5:16 pm | N/A 2032-12-13 | Invivyd Inc. | IVVD | Andersen Jill Chief Legal Officer Secretary | 300,000 | $0 | 300,000 (Direct) | View |
| 2022-12-14 Option Award | 2022-12-16 5:14 pm | N/A 2032-12-13 | Invivyd Inc. | IVVD | Schmidt Peter Chief Medical Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-16 5:11 pm | N/A 2032-12-15 | Invivyd Inc. | IVVD | Gowler Jeremy COO & CCO | 625,000 | $0 | 625,000 (Direct) | View |
| 2022-12-14 Option Award | 2022-12-16 5:09 pm | N/A 2032-12-13 | Invivyd Inc. | IVVD | Hering David Chief Executive Officer | 1,600,000 | $0 | 1,600,000 (Direct) | View |
| 2022-12-06 Option Award | 2022-12-06 5:55 pm | N/A 2032-12-05 | Invivyd Inc. | IVVD | Schmidt Peter Chief Medical Officer | 300,000 | $0 | 300,000 (Direct) | View |
| 2022-12-06 Ownership | 2022-12-06 5:52 pm | N/A N/A | Invivyd Inc. | IVVD | Schmidt Peter Chief Medical Officer | 0 | $0 | 193,671 (Direct) | View |
| 2022-11-03 Option Award | 2022-11-04 4:06 pm | N/A 2032-11-02 | Invivyd Inc. | IVVD | Andersen Jill Chief Legal Officer Secretary | 175,000 | $0 | 175,000 (Direct) | View |
| 2022-10-20 Option Award | 2022-10-24 4:52 pm | N/A 2032-10-19 | Invivyd Inc. | IVVD | Lindenboom Christine Director | 150,000 | $0 | 150,000 (Direct) | View |
| 2022-07-05 Option Award | 2022-07-06 4:05 pm | N/A 2032-07-04 | Adagio Therapeutics Inc. | ADGI | Hering David Chief Executive Officer | 2,000,000 | $0 | 2,000,000 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 5:01 pm | N/A 2032-06-21 | Adagio Therapeutics Inc. | ADGI | MEANWELL CLIVE Director 10% Owner | 150,000 | $0 | 150,000 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 4:44 pm | N/A 2032-06-21 | Adagio Therapeutics Inc. | ADGI | Berry Tamsin Director | 150,000 | $0 | 150,000 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 4:40 pm | N/A 2032-06-21 | Adagio Therapeutics Inc. | ADGI | Elia Marc M28 Capital Management LP See Remarks | 150,000 | $0 | 150,000 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 4:36 pm | N/A 2032-06-21 | Adagio Therapeutics Inc. | ADGI | Mayer Howard Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 4:35 pm | N/A 2032-06-21 | Adagio Therapeutics Inc. | ADGI | WYZGA MICHAEL S Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 4:32 pm | N/A 2032-06-21 | Adagio Therapeutics Inc. | ADGI | Miller Redonda Director | 44,178 | $0 | 44,178 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 4:31 pm | N/A 2032-06-21 | Adagio Therapeutics Inc. | ADGI | Heyman Tomas J. Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 4:28 pm | N/A 2032-06-21 | Adagio Therapeutics Inc. | ADGI | MCGUIRE TERRANCE Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-03-28(A) Ownership | 2022-04-06 5:02 pm | N/A N/A | Adagio Therapeutics Inc. | ADGI | Cox Christopher T Population Health Equity Partners VII L.P. Population Health Equity Partners III GP LLC Population Health Equity Partners III L.P. Population Health Equity Partners VII GP LLC See Explanation of Responses | 0 | $0 | 679,822 (Indirect) | View |
| 2022-03-28 Ownership | 2022-04-01 4:15 pm | N/A N/A | Adagio Therapeutics Inc. | ADGI | Elia Marc M28 Capital Management LP SEE REMARKS | 0 | $0 | 6,398,250 (Indirect) | View |
| 2022-03-03 Other | 2022-04-01 4:08 pm | N/A N/A | Adagio Therapeutics Inc. | ADGI | Adimab LLC See Remarks 10% Owner | 1,158,089 | $0 | 27,845,995 (Direct) | View |
| 2022-03-28 Ownership | 2022-03-30 9:57 pm | N/A N/A | Adagio Therapeutics Inc. | ADGI | MEANWELL CLIVE See Explanation of Responses. | 0 | $0 | 1,201,680 (Indirect) | View |
| 2022-03-28 Ownership | 2022-03-30 9:52 pm | N/A N/A | Adagio Therapeutics Inc. | ADGI | Cox Christopher T See Explanation of Responses | 0 | $0 | 679,822 (Indirect) | View |
| 2022-03-28 Ownership | 2022-03-30 6:19 pm | N/A N/A | Adagio Therapeutics Inc. | ADGI | Polaris Venture Partners V L.P. Polaris Venture Partners Entrepreneurs' Fund V L.P. Polaris Venture Partners Founders' Fund V L.P. Polaris Venture Partners Special Founders' Fund V L.P. Polaris Venture Management Co. V L.L.C. Polaris Partners IX L.P. Polaris Partners GP IX L.L.C. Polaris Healthcare Technology Opportunities Fund L.P. Polaris Healthcare Technology Opportunities Fund GP L.L.C. Flint Jonathan A See Remarks | 0 | $0 | 8,531,700 (Indirect) | View |
| 2022-01-30 Option Award | 2022-02-01 6:18 pm | N/A 2032-01-29 | Adagio Therapeutics Inc. | ADGI | Hershberger Elham Chief Development Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2022-01-30 Option Award | 2022-02-01 6:17 pm | N/A 2032-01-29 | Adagio Therapeutics Inc. | ADGI | Hering David Chief Operating Officer | 475,000 | $0 | 475,000 (Direct) | View |
| 2022-01-30 Option Award | 2022-02-01 6:15 pm | N/A 2032-01-29 | Adagio Therapeutics Inc. | ADGI | Henderson Jane Chief Financial Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2022-01-30 Option Award | 2022-02-01 6:14 pm | N/A 2032-01-29 | Adagio Therapeutics Inc. | ADGI | Gerngross Tillman U. Chief Executive Officer 10% Owner | 175,000 | $0 | 175,000 (Direct) | View |
| 2022-01-30 Option Award | 2022-02-01 6:13 pm | N/A 2032-01-29 | Adagio Therapeutics Inc. | ADGI | Dabora Rebecca Chief Tech and Manuf Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2022-01-30 Option Award | 2022-02-01 6:11 pm | N/A 2032-01-29 | Adagio Therapeutics Inc. | ADGI | Connolly Lynn Chief Medical Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2022-01-30 Option Award | 2022-02-01 6:10 pm | N/A 2032-01-29 | Adagio Therapeutics Inc. | ADGI | Andersen Jill Chief Legal Officer Secretary | 575,000 | $0 | 575,000 (Direct) | View |